Australian industry fears U.S. seeks biologics changes in TPP certification

The Australian Chamber of Commerce and Industry, in its submission to an Australian Senate committee tasked with reviewing the Trans-Pacific Partnership, expressed concern that the United States would demand that Australia take on additional commitments on biologic drugs before the agreement can enter into force for the country -- citing precedent in the certification process of the two countries' bilateral free trade agreement. "We welcome the Australian Government's resistance to calls for increased IP terms, particularly on Biologics as negotiated...